Søg i kliniske forsøg efter: Decide2Quit
I alt 1 resultater
-
University of Massachusetts, WorcesterJohns Hopkins University; University of Alabama at BirminghamAfsluttet
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- Aptis Medical
- Korean Society of Spine Surgery
- Hospital ASEPEYO Sant Cugat
- Hospital Durand, Argentina
- Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
- Alma Lasers Inc.
- Everett Meyer
- Mª Victoria Maestre Sanchez
- Nacuity Pharmaceuticals, Inc.
- iCAD
- Apollo Neuroscience, Inc.
- RMIT University, Melbourne, Australia
- Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
- Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
- Neurophth Therapeutics Inc
- GFI
- ASST Cremona, Cremona
- Agency for Science, Technology and Research
- Kupfer, David J., M.D.
- Eurofins Genoma
- Se den fulde liste
Medicinske tilstande
- Post Covid-19 tilstand
- Nyrefunktionsforstyrrelse
- Social angst
- Kirurgisk patient
- Henfald
- Kunstig bugspytkirtel
- Dislokation, Skulder
- PD-1 Refractory Advanced Melanom
- STEMI - ST-segment Elevation Myokardieinfarkt
- Anaplastisk storcellet lymfom
- Hospitalserhvervet tryksår
- Sporadisk
- Aldersrelateret høretab
- Nakkemasse
- Anatomisk fase 2A brystkræft AJCC v8
- Ekstraartikulær fraktur
- LAV OVARIERESPONS
- Optimys lårbensstamme
- Tobak, alkohol, receptpligtig medicin og ulovlig brug af stoffer
- Nøjagtighed og præcision af ikke-invasiv måling
- Se den fulde liste
Narkotikainterventioner
- Intravenøs deferipron
- Oxycodon/acetaminophen 5/325 mg
- Letrozol
- GLPG1837 flere stigende doser
- MLN2480
- Midazolam
- Standardbehandling (SOC) for COVID-19
- TPN-101
- Capecitabin/cisplatin
- PD-1/PD-L1-hæmmer
- THC
- Olopatadin
- OnabotulinumtoxinA
- Antikolinergisk
- Camptosar
- Fospropofol dinatrium, propofol
- RDX227675
- Capecitabin og IMRT (hvis randomiseret til denne arm)
- Intravenøs formulering af PD-0332991
- Desvenlafaxin
- Se den fulde liste
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Georgia
- Contract Research Organizations in Ireland
- Contract Research Organizations in Israel
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Philippines
- Contract Research Organizations in Poland
- Contract Research Organizations in South Korea
- Contract Research Organizations in Taiwan
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in United States
- CRO list by country